Study of the Immune Response After Vaccination in Multiple Myeloma Patients
The Immune Response Following Vaccination in Multiple Myeloma Patients: A Prospective Pilot Study
Sponsor: Vince Lombardi Cancer Clinic
This observational or N/A phase trial investigates Multiple Myeloma and Myeloma, Multiple and is currently completed. Vince Lombardi Cancer Clinic leads this study, which shows 10 recorded versions since 2014 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
10 versions recorded-
Nov 2024 — Present [monthly]
Completed
-
Sep 2024 — Nov 2024 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Mar 2019 — Jan 2021 [monthly]
Completed
Status: Active Not Recruiting → Completed
▶ Show 5 earlier versions
-
Feb 2019 — Mar 2019 [monthly]
Active Not Recruiting
-
Aug 2018 — Feb 2019 [monthly]
Active Not Recruiting
-
Jun 2018 — Aug 2018 [monthly]
Active Not Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Active Not Recruiting
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Active Not Recruiting NA
First recorded
Dec 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Vince Lombardi Cancer Clinic
- Wake Forest University Health Sciences
For direct contact, visit the study record on ClinicalTrials.gov .